Uncategorized 

Apple Inc. Stock Rises Monday, Outperforms Market

The stock for one of Apple Inc.’s component suppliers, Cirrus Logic Inc. (CRUS), surged at the open of trading this morning, and the company was followed closely in the media by many investors. The milestone stock, which gained 4.44 percent in the opening moments of trading on the NASDAQ, carried strong momentum as other stock indices followed with moderate gains as well. The price of CRUS stock was around $124 at the start of trade. Apple Inc. stock rose by 1.98 percent to $216.57, outperforming its peer S&P 500 (SPX)…

Read More
MARKET REPORTS 

McAfee Files for Return to Public Markets

McAfee has filed with the U.S. Securities and Exchange Commission to go public. After 14 years of ownership by Intel, the company will raise capital to support its global expansion. The Palo Alto, California-based cybersecurity company will be the 10th tech or communication firm to go public in the past 12 months, a wave that’s under way despite technology stocks tumbling in the first quarter of 2019. McAfee will raise $1.4 billion to pay down debt, but management said it would use some of the proceeds to grow the business,…

Read More
Uncategorized 

Asian Markets Mixed After Wall Street Starts the Week Strong

Asian markets traded mixed on Thursday following strong opening gains on Wall Street on Wednesday. The Nikkei 225 ended the day flat to the middle while the S&P 500 closed slightly lower, led by declines in technology stocks and a drop in financials. US markets rallied early this week on news that President Donald Trump plans to meet with China’s Xi Jinping in late June to discuss trade war issues. The escalation of the US-China trade war would trigger a severe slowdown in both economies, and hurt profitability and investment.…

Read More
MARKET REPORTS 

Bruising Stock Selloff Underscores Market Risk During Coronavirus Turbulence

The recent market selloff around the timing of the coronavirus coronavirus (CFC) outbreak and increased stock market volatility is a big indicator of investor nervousness around the geopolitical landscape, according to market and health-care market professionals. “This is happening as the risk of the international community confronting the worldwide phenomenon of CFC infection rises,” said Angela Iffland, Managing Director of Echelon Wealth Partners, and Head of Global Public Policy on the 7th Annual Global Health Care Industry Summit held in New York City, May 9-10, 2019. “Investors want to know…

Read More
Uncategorized 

Treasury Yields Shrug Off Stock-Market Rally Ahead of Fed Meeting

Apple shares see a sharp spike in trading on Wednesday, after the company reports its first-quarter sales figures for the current fiscal year. The earnings beat predictions and Apple shares sees a subsequent spike. The stock was up 3.0 percent at the time of this writing. Apple announced its third-quarter results Tuesday and the tech giant posted quarterly sales of $52.9 billion and profits of $11.8 billion, which beat revenue and profits forecasts from analysts. According to the company, sales in the quarter were up 10 percent from the same…

Read More
Uncategorized 

Apple Inc. Stock Outperforms Market on Strong Trading Day

Apple shares see a sharp spike in trading on Wednesday, after the company reports its first-quarter sales figures for the current fiscal year. The earnings beat predictions and Apple shares sees a subsequent spike. The stock was up 3.0 percent at the time of this writing. Apple announced its third-quarter results Tuesday and the tech giant posted quarterly sales of $52.9 billion and profits of $11.8 billion, which beat revenue and profits forecasts from analysts. According to the company, sales in the quarter were up 10 percent from the same…

Read More
MARKET REPORTS 

Stock-Market Rout: Why it’s Too Early to Call Tech Plunge the Start of a Correction

There are certainly a lot of headwinds weighing on the tech sector, and the day after the market plunged, many people made the assumption that a tech-sector correction has begun. The bottom line: We have too many concerns and too many questions left to answer. Last week, Nasdaq fell 7%, and the S&P 500 fell over 2%. The Dow Jones Industrial Average is down close to 12%. The Dow’s decline is larger than the traditional correction that marks market bottoms. Tech is getting hit particularly hard. Following the first decline…

Read More
Uncategorized 

Apple’s Market Value Slips Below $2 Trillion. The Tech Rout Continues

Apple’s market value slipped below $2 trillion for the first time in more than two years on Wednesday after sliding more than five percent in premarket trading as investors started to pull back on tech holdings. The world’s most valuable publicly listed company also saw some of its crown taken from Microsoft by ExxonMobil, the oil giant that closed just above Apple’s market value. Twitter was also hit, knocking 5.07 percent lower as investors speculated that Twitter will face pressure from regulators. Twitter shares have now lost more than a…

Read More
FINANCE 

Asian Markets Rise Despite Warning on Global Recovery

Asian markets rose on Thursday following a warning of a slowdown in global growth by the International Monetary Fund. Despite the warning, European shares rose. Stocks ticked up across Asia overnight after the IMF warned of slower global growth. In Japan, stocks surged, up more than 2.5%, while Hong Kong closed more than 1.8% higher. A rate hike by the Bank of Japan caused the dollar to strengthen further, pushing the Japanese currency down more than 1% against the U.S. dollar. The IMF cut its forecast for global growth to…

Read More
Uncategorized 

Johnson & Johnson Stock Outperforms Market on Strong Trading Day

Johnson & Johnson stock traded above the 52-week high on Wednesday. JNJ stock was around 3.14%. The blue-chip stock has climbed 8.2% in the past three months, thanks in part to the successful launch of the soon-to-be-listed JNJ PARADIGM 3.0. JNJ PARADIGM 3.0 is a data transfer system for collecting, storing, and delivering life science applications and clinical trial results. Research and development used its PARADIGM technology to develop Arimidex, one of the largest-selling type II beta-blockers on the market. The launch was a critical milestone for JNJ’s competitive position,…

Read More